Health, biotechnology and wellness
Diagnostics, medical devices, therapeutics, veterinary products, peptides, telehealth platforms, wellness brands, longevity companies, functional medicine businesses, specialty pharmacies, supplements, and health technology companies.
What makes this sector different
Health, biotechnology, wellness, longevity, peptide, and telehealth companies operate at the intersection of science, technology, intellectual property, regulation, and commerce. Success often depends not only on protecting innovation, but also on structuring vendor relationships, research collaborations, platform agreements, licensing arrangements, manufacturing and distribution networks, marketing programs, and investment transactions in a way that supports growth while managing ris
This is the sector where a graduate background in biochemistry stops being a credential on a page and starts creating practical value. Understanding the underlying science allows legal strategy to be informed by the realities of product development, research, commercialization, and highly regulated business operations.
Typical matters
Patenting a diagnostic or device
Prior art and patentability work on the underlying method, then claims drafted to survive both examination and the eligibility challenges that diagnostics attract.
Supplement and wellness compliance
Label review, ingredient safety, structure and function claim substantiation, and manufacturing practice support before a product ships.
Clinical research and IRB setup
Standing up review board compliant studies that reduce liability and give you evidence you are actually allowed to cite in marketing.
University and institutional agreements
Sponsored research agreements, material transfer, data use agreements and the publication terms that decide whether you can still file afterwards.
Peptide Sourcing, Manufacturing, Testing, Fulfillment & Supply-Chain Issues
Advising peptide companies, wellness brands, and health innovation businesses on sourcing arrangements, manufacturing relationships, laboratory testing agreements, fulfillment operations, distribution networks, vendor contracts, and supply-chain risk management.
Research Peptide Intellectual Property Risks
Helping peptide companies assess patent risks, navigate freedom-to-operate concerns, develop licensing strategies, and protect innovation in competitive markets.
Veterinary and animal health products
Prior art and patentability work for clinics, pet product entrepreneurs and animal health ventures, an area the firm has repeat experience in.
Licensing a therapeutic or platform out
Valuation, field of use limits, milestones and royalty structure, then the licence itself drafted and negotiated.
Services used most in this sector
Patent
Searches, freedom to operate, and provisional through PCT filings on methods, formulations and devices.
View service
IP Commercialization, Investment & Policy Advisory
FDA pathway strategy, supplement rules, IRB protocols and the claims you are permitted to make.
View service
Tech Transactions
Sponsored research, material transfer, data use and licensing agreements with institutions and partners.
View serviceQuestions from this sector
We are presenting a poster at a conference next month. Is that a problem?
Potentially a serious one. A conference poster is a public disclosure, and in most countries outside the United States any disclosure before filing destroys patentability outright. The United States allows a twelve month grace period from your own disclosure, but that does not help you in Europe, China or Japan. If the abstract is already published, tell us the publication date on the first call, because it changes what remains available.
Our study was run at a university. Who owns the results?
Read the sponsored research agreement, because that document already answered the question and the answer is frequently not what founders assume. Standard institutional terms often reserve significant rights to the university, including publication rights that can trigger a disclosure before you are ready to file. This is one of the most common and most expensive things to discover late.
Can we say our supplement improves sleep?
It depends entirely on how the sentence is constructed and what evidence sits behind it. Structure and function claims are permitted within limits and with substantiation. A claim that the product treats, prevents or cures a condition moves the product into drug territory and a completely different regulatory regime. The wording and the evidence need to be settled together, before the label is printed and before the marketing copy is written.
Start with a 30 minute consultation.
A $50 video call covering your goals, your timeline and the documents you send ahead. The $50 is credited toward your fee when the firm takes your matter on.
